591 results on '"Aisner, Joseph"'
Search Results
2. Paravertebral Nerve Block With Liposomal Bupivacaine for Pain Control Following Video-Assisted Thoracoscopic Surgery and Thoracotomy
3. Genomic characterization of malignant pleural mesothelioma and associated clinical outcomes
4. Efficiency with Trade-Offs and Crossover Designs
5. Sample Size and Power Calculations
6. Sequential Designs and Methods—Part III: Classical Group Sequential Trials
7. Analysis of Covariance and Stratified Analysis
8. Sequential Designs and Methods—Part I: Expected Sample Size and Two-Stage Phase II Trials in Oncology
9. Concepts and Methods of Statistical Designs
10. Sequential Designs and Methods—Part II: Monitoring Safety and Futility
11. Estimand, Intercurrent Events, and Missing Data
12. Monitoring the Maximum Information and Adaptive Sample Size Designs
13. Clinical Trials with Predictive Biomarkers
14. Multiplicity Issues and Methods for Controlling the Type I Error Rate
15. Seamless Phase II/III: Select-the-Winner Design
16. Statistical Significance and p-Values
17. Overview
18. Regression Analysis of Survival Data
19. A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors
20. Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinoma
21. Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer
22. Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single Institution
23. Association of Target Volume Margins With Locoregional Control and Acute Toxicities for Non-small cell lung cancer Treated With Concurrent Chemoradiation Therapy
24. Receipt of recommended surveillance with imaging in elderly survivors of early stage non-small cell lung cancer
25. Dosimetric Predictors of Symptomatic Cardiac Events After Conventional-Dose Chemoradiation Therapy for Inoperable NSCLC
26. Variations in Initiation Dates of Chemotherapy and Radiation Therapy for Definitive Management of Inoperable Non–Small Cell Lung Cancer Are Associated With Decreases in Overall Survival
27. A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors
28. A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer
29. A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850
30. Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer
31. Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration
32. Supplementary Data from Randomized Phase II Multicenter Trial of Two Schedules of Lapatinib as First- or Second-Line Monotherapy in Patients with Advanced or Metastatic Non–Small Cell Lung Cancer
33. Supplementary Figures 1-6, Supplementary Tables 1-5 from First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid Tumors
34. Ambulatory pulse oximetry as a clinical aid for the diagnosis and treatment response of radiation pneumonitis
35. Vandetanib Plus Chemotherapy for Induction Followed by Vandetanib or Placebo As Maintenance for Patients with Advanced Non–Small-Cell Lung Cancer: A Randomized Phase 2 PrECOG Study (PrE0501)
36. Clinical outcomes and immune phenotypes associated with STK11 co-occurring mutations in non-small cell lung cancer
37. Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501)
38. E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer
39. Epidermal Growth Factor Receptor, C-kit, and Her2/neu Immunostaining in Advanced or Recurrent Thymic Epithelial Neoplasms Staged According to the 2004 World Health Organization in Patients Treated with Octreotide and Prednisone: An Eastern Cooperative Oncology Group Study
40. A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies
41. Statistical Design, Monitoring, and Analysis of Clinical Trials
42. Overexpression of excision repair cross-complementing 1 gene associates with higher risk of therapeutic failure after definitive chemoradiation for unresectable non-small cell lung cancer
43. A phase I clinical trial of 12- O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignancies
44. Combining radiation therapy and immunotherapy for lung cancers: a narrative review
45. Rational drug sequencing of paclitaxel, gemcitabine and carboplatin in patients with untreated stage IV and select stage IIIB non-small cell lung cancer
46. Tumors of the Pleura and Mediastinum
47. Contributors
48. A Novel Acquired Exon 20 EGFR M766Q Mutation in Lung Adenocarcinoma Mediates Osimertinib Resistance but is Sensitive to Neratinib and Poziotinib
49. Local treatment of synchronous oligometastatic non-small cell lung cancer (NSCLC)—current consensus and future perspectives
50. Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non–Small Cell Lung Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.